Our findings suggested that inosine significantly increased M1 macrophage markers CD86 and iNOS in the tumor microenvironment and enhanced the anti-tumor activity of M1 macrophages, effectively inhibiting CRC progression and metastasis potential. The gene discussed is NOS2; the disease is neoplasm.